Tech Company Financing Transactions

D-Pharm Funding Round

On 5/15/2006, D-Pharm received $10 million in Series A investment from Clal Biotechnology Industries, Pitango Venture Capital and Gemini Israel Funds.

Transaction Overview

Company Name
D-Pharm
Announced On
5/15/2006
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

Clal Biotechnology Industries (Lead Investor) (Ruben Krupik)

Pitango Venture Capital (Lead Investor) (Ruti Alon)

Gemini Israel Funds

Israel Healthcare Ventures (Hadar Ron)

Proceeds Purpose
These resources will enable us to fund the further development of our main product, DP-b99 for acute stroke currently in Phase 2 clinical trials, as well as to complete pre-clinical development of our lead candidate for Alzheimer`s disease.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
47 Hulfish St. 310
Princeton, NJ 08642
USA
Phone
(215) 588-8484
Website
www.dpharm.com
Email Address
[email protected]
Overview
D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company's particular area of interest is in developing innovative medicine for degenerative and age-related disorders.
Profile
D-Pharm LinkedIn Company Profile
Social Media
D-Pharm Company Twitter Account
Company News
D-Pharm News
Facebook
D-Pharm on Facebook
YouTube
D-Pharm on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alexander Kozak
  Alexander Kozak LinkedIn Profile  Alexander Kozak Twitter Account  Alexander Kozak News  Alexander Kozak on Facebook
VP - Finance
Ofra Yamin
  Ofra Yamin LinkedIn Profile  Ofra Yamin Twitter Account  Ofra Yamin News  Ofra Yamin on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/15/2006: Identity Engines venture capital transaction
Next: 5/15/2006: Toodou.com venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.